Endogenous GLP-1 is involved in β-amyloid protein-induced memory impairment and hippocampal neuronal death in rats

Brain Research

Volumn 878, Issue 1-2, 2000, Pages 194-198

  Oka, Jun Ichiro ^a   Suzuki, Eiko ^a   Kondo, Yoshiko ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Exendin (5 39); Glucagon like peptide 1; Hippocampus; Memory; Amyloid protein

Indexed keywords

AMYLOID BETA PROTEIN; EXENDIN[5-39]; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPUS; MALE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT;

AMYLOID BETA-PROTEIN; ANIMAL; CELL DEATH; DNA FRAGMENTATION; DRUG COMBINATIONS; GLUCAGON; HIPPOCAMPUS; MALE; MEMORY; MEMORY DISORDERS; NEURONS; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; RATS; RATS, WISTAR; RECEPTORS, GLUCAGON; SUPPORT, NON-U.S. GOV'T;

EID: 0034730477     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02741-4     Document Type: Article

References (19)

1. Ambrogi-Lorenzini C.G., Baldi E., Bucherelli C., Sacchetti B., Tassoni G. Role of ventral hippocampus in acquisition, consolidation and retrieval of rat's passive avoidance response memory trace. Brain Res. 768:1997;242-248.
2. Forloni G.C.R., Smiroldo S., Verga L., Salmona M., Tagliavini F., Angeretti N. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. Neuroreport. 4:1993;523-526.
3. Göke B., Göke R., Fehmann H.-C., Bode H.-P. Physiology and pathophysiology of GLP-1. Lefebvre P.J. Glucagon III. Handbk. Exp. Pharmacol. Vol. 123:1996;275-309 Springer-Verlag, Berlin.
4. Hicks T.P., Krasteniakov N.V., Jackson M., Donnelly S.M., Chakravarthy B., Ohannessian L., Oka J.-I. Altered electrophysiological expression of synaptic plasticity and infrared spectroscopic tissue composition in long-term β-amyloid-treated rats. Acta Medica et Biologica. 48:2000;31-38.
5. Itoh A., Akaike T., Sokabe M., Nitta A., Iida R., Olariu A., Yamada K., Nabeshima T. Impairments of long-term potentiation in hippocampal slices of β-amyloid-infused rats. Eur. J. Pharmacol. 382:1999;167-175.
6. Itoh A., Nitta A., Nadai M., Nishimura K., Hirose M., Hasegawa T., Nabeshima T. Dysfunction of cholinergic and dopaminergic neuronal systems in β-amyloid protein-infused rats. J. Neurochem. 66:1996;1113-1117.
7. Kitamura Y., Taniguchi T., Shimohama S. Apoptotic cell death in neurons and glial cells: implications for Alzheimer's disease. Jpn. J. Pharmacol. 79:1999;1-5.
8. Montrose-Rafizadeh C., Yang H., Rodgers B.D., Beday A., Pritchette L.A., Eng J. High potency antagonists of the pancreatic glucagon-like peptide-1 receptor. J. Biol. Chem. 272:1997;21201-21206.
9. Nitta A., Fukuta T., Hasegawa T., Nabeshima T. Continuous infusion of β-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn. J. Pharmacol. 73:1997;51-57.
10. Nitta A., Itoh A., Hasegawa T., Nabeshima T. β-Amyloid protein-induced Alzheimer's disease animal model. Neurosci Lett. 170:1994;63-66.
11. Oka J.-I., Goto N., Kameyama T. Glucagon-like peptide-1 modulates neuronal activity in the rat's hippocampus. Neuroreport. 10:1999;1643-1646.
12. Oka J.-I., Suzuki E., Goto N., Kameyama T. Endogenous GLP-1 modulates hippocampal activity in β-amyloid protein-treated rats. Neuroreport. 10:1999;2961-2964.
13. O'Shea D., Gunn I., Chen X., Bloom S., Herbert J. A role for central glucagon-like peptide-1 in temperature regulation. Neuroreport. 7:1996;830-832.
14. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd Edition:1986;Academic Press, San Diego.
15. Sarter M., Bodewitz G., Stephens D.N. Attenuation of scopolamine-induced impairment of spontaneous alternation behaviour by antagonist but not inverse agonist and agonist β-carbolines. Psychopharmacology. 94:1988;491-495.
16. Suzuki E., Kondo Y., Oka J.-I. A role of endogenous GLP-1 in amnesia and neuronal death induced by continuous i.c.v. infusion of β-amyloid protein in rat. Jpn. J. Pharmacol. 82:2000;236P.
17. Tang-Cheristensen M., Larsen P.J., Göke R., Fink-Jensen A., Jessop D.S., Møller M., Sheikh S.P. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am. J. Physiol. 271:1996;R848-R856.
18. Turton M.D., O'Shea D., Gunn I., Beak S.A., Edwards C.M.B., Meeran K., Choi S.J., Taylor G.M., Heath M.M., Lambert P.D., Wilding J.P.H., Smith D.M., Ghatel M.A., Herbert J., Bloom S.R. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature. 379:1996;69-72.
19. Wilcock G.K., Esiri M.M. Plaques, tangles and dementia. A quantitative study. J. Neurol. Sci. 56:1982;343-356.